首页 | 本学科首页   官方微博 | 高级检索  
     


Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout
Authors:Tran Ai P  Edelman Jack
Affiliation:Sir Charles Gairdner Hospital, Rheumatology, Perth, Western Australia, Australia. aptran7@msn.com
Abstract:
Since the discovery of the inflammasome, interleukin 1 production has been found to be integral in the pathophysiology of gout. Interleukin 1 inhibition by Anakinra has been shown to effective for the treatment of gout. We report three cases of resistant chronic tophaceous gout who responded to anakinra subcutaneous injections on an intermittent basis.
Keywords:anakinra  gout  inflammasome  interleukin‐1 inhibition  tophaceous
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号